Back

Adaptimmune Therapeutics PLC Quote, Financials, Valuation and Earnings

The Next Nvidia?

Go here now for this breaking story.

Sell

ADAP
Adaptimmune Therapeutics PLC

Last Price:

0.87

Seasonality Move:

-9.46%

7 Day Trial

ALL ACCESS PASS

$ 7

Jeff Bezos's Plan Exposed

And for investors who get in now profits could be massive - click here for full story.

Adaptimmune Therapeutics PLC Price Quote

$0.87

-0.01 (-1.2%)

(Updated: June 25, 2024 at 6:55 PM ET)

Adaptimmune Therapeutics PLC Key Stats

Sell

Adaptimmune Therapeutics PLC (ADAP) is a Sell

Day range:

$0.88 - $0.92

52-week range:

$0.42 - $2.05

Dividend yield:

P/E ratio:

0.00

P/S ratio:

10.56

P/B ratio:

9.23%

Volume:

754.2K

Avg. volume:

1.8M

1-year change:

-7.31%

Market cap:

$225M

Revenue:

$60.3M

EPS:

$-0.66

How Much Does Adaptimmune Therapeutics PLC Make?

How Much Are Adaptimmune Therapeutics PLC's Sales Annually?
ADAP Revenues are $60.3M
How Much Profit Does Adaptimmune Therapeutics PLC's Make A Year?
ADAP net income is -$113.9M

Is Adaptimmune Therapeutics PLC Growing As A Company?

What Is Adaptimmune Therapeutics PLC's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.88%
What Is Adaptimmune Therapeutics PLC's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

Adaptimmune Therapeutics PLC Stock Price Performance

Did Adaptimmune Therapeutics PLC Stock Go Up Last Month?
Adaptimmune Therapeutics PLC share price went down by -16.13% last month
Did ADAP's Share Price Rise Over The Last Year?
ADAP share price fell by -7.31% over the past 1 year

What Is Adaptimmune Therapeutics PLC 52-Week High & Low?

What Is Adaptimmune Therapeutics PLC’s 52-Week High Share Price?
Adaptimmune Therapeutics PLC has traded as high as $2.05 over the past 52 weeks
What Is Adaptimmune Therapeutics PLC’s 52-Week Low Share Price?
Adaptimmune Therapeutics PLC has traded as low as $0.42 over the past 52 weeks

Adaptimmune Therapeutics PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Adaptimmune Therapeutics PLC?

How Much Debt Does Adaptimmune Therapeutics PLC Have?
Total long term debt quarterly is $0
How Much Cash Does Adaptimmune Therapeutics PLC Have?
Cash and short term investments quarterly total is $143.7M
What Is Adaptimmune Therapeutics PLC’s Book Value Per Share?
Book value per share is 0.10

Is Adaptimmune Therapeutics PLC Cash Flow Positive?

What Is ADAP Cash Flow From Operations?
Cash flow from operations (TTM) is -$135.5M
What Is Adaptimmune Therapeutics PLC’s Cash Flow From Financing?
Cash flow from financing (TTM) is $29.9M
What Is Adaptimmune Therapeutics PLC’s Cash Flow From Investing?
Cash flow from investing (TTM) is $127.8M

Adaptimmune Therapeutics PLC Return On Invested Capital

Is Management Doing A Good Job?
ADAP return on invested capital is -225.37%
What Is Adaptimmune Therapeutics PLC Return On Assets?
ROA measures how assets are converting to revenues and is -55.65%
What Is ADAP Return On Equity?
ROE is a measure of profitability and is -225.37%

Adaptimmune Therapeutics PLC Earnings Date & Stock Price

What Is Adaptimmune Therapeutics PLC's Stock Price Today?
A single share of ADAP can be purchased today for 0.88
What Is Adaptimmune Therapeutics PLC’s Stock Symbol?
Adaptimmune Therapeutics PLC trades on the nasdaq under the ticker symbol: ADAP
When Is Adaptimmune Therapeutics PLC’s Next Earnings Date?
The next quarterly earnings date for Adaptimmune Therapeutics PLC is scheduled on August 9, 2024
When Is ADAP's next ex-dividend date?
Adaptimmune Therapeutics PLC's next ex-dividend date is June 26, 2024
How To Buy Adaptimmune Therapeutics PLC Stock?
You can buy Adaptimmune Therapeutics PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Adaptimmune Therapeutics PLC Competitors

Who Are Adaptimmune Therapeutics PLC's Competitors?
Below is a list of companies who compete with Adaptimmune Therapeutics PLC or are related in some way:
- Autolus Therapeutics PLC (AUTL)
- Biodexa Pharmaceuticals Plc (BDRX)
- Mereo BioPharma Group PLC (MREO)
- NuCana PLC (NCNA)
- TC BioPharm (Holdings) PLC (TCBP)

Adaptimmune Therapeutics PLC Dividend Yield